KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medtronic (MDT) Depreciation & Amortization (CF) (2016 - 2026)

Medtronic's Depreciation & Amortization (CF) history spans 13 years, with the latest figure at $749.0 million for Q1 2026.

  • For Q1 2026, Depreciation & Amortization (CF) rose 9.5% year-over-year to $749.0 million; the TTM value through Jan 2026 reached $3.1 billion, up 15.21%, while the annual FY2025 figure was $2.9 billion, 8.08% up from the prior year.
  • Depreciation & Amortization (CF) for Q1 2026 was $749.0 million at Medtronic, up from $745.0 million in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $840.0 million in Q2 2025 and bottomed at $649.0 million in Q1 2024.
  • The 5-year median for Depreciation & Amortization (CF) is $675.0 million (2024), against an average of $694.5 million.
  • The largest annual shift saw Depreciation & Amortization (CF) fell 4.42% in 2024 before it increased 28.44% in 2025.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at $671.0 million in 2022, then rose by 0.15% to $672.0 million in 2023, then rose by 0.45% to $675.0 million in 2024, then rose by 10.37% to $745.0 million in 2025, then rose by 0.54% to $749.0 million in 2026.
  • Per Business Quant, the three most recent readings for MDT's Depreciation & Amortization (CF) are $749.0 million (Q1 2026), $745.0 million (Q4 2025), and $748.0 million (Q3 2025).